IL17A and colitis: Additionally, the UAF1 inhibitor demonstrated a significant suppression of the levels of inflammatory markers (TNF-α, IL-6, IL-17, and IL-1β) in the colon tissue of colitis mice (P < 0.05 and P < 0.01, Fig. 2F–I).